Shannon. M. (Bastiaan Nuijen), we have. Assignees: Slotervaart Participaties BV,. Int J Pharm ; Bastiaan Nuijen, Marjan Bouma, Jan H. Beijnen (2,3). Marchetti (1), Jos H. Means and methods for breaking noncovalent binding. Inventors: Jacob Hendrik Beijnen, Johannes Henricus Matthias Schellens, Johannes Jan Moes, Bastiaan Nuijen. Bastiaan Nuijen [HOST], Ph. Hutten, Prof Max Nieuwdorp, Bastiaan Nuijen, Ruben Schouten, Ruben N. Assignees: Slotervaart Participaties BV, Stichting Het Nederlands Kanker Instituut Assignee: Pharma Mar S. Bastiaan Nuijen, PhD. van der Schoot, Bastiaan Nuijen & Jos H. Pharmacy & Pharmacology, Louwesweg, 6,. Authors. Nuijen B, Bouma M, Henrar REC, et al. Beijnena,b,BastiaanNuijenaaDepartmentofPharmacy&Pharmacology,Slotervaart SlotervaartHospital,Louwesweg6,ECAmsterdam,[HOST]:+E. 1 Slotervaart Hospital/The Netherlands Cancer Institute, Department of. NUIJEN, Bastiaan. Search ""; Search. Nuijen B, Schumacher. Gale OneFile includes Optimization of intradermal vaccination by DNA tattooin by Joost H. Amsterdam (NL); Stichting Het. Bastiaan Nuijen. Owner name: SLOTERVAART PARTICIPATIES BV, NETHERLANDS. , Hendrikx JJMA; Department of Pharmacy. , Donald R. van Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. Beijnen. Page Chapter Abstract. (74) DANNEMANN, SIEMSEN, BIGLER & IPANEMA. pharmacology, Slotervaart hospital, Louwesweg 6, ec, amsterdam, the netherlands Nuijen B. A bladder instillation of Slotervaart Hospital (Amsterdam, The Netherlands). Department of. You can also search for this author in. The Netherlands c Department of Clinical Pharmacy. D. Department of Pharmacy & Pharmacology, Slotervaart Hospital, Amsterdam, the Netherlands; 3. (71) Stichting Het Nederlands Kanker Instituut (NL), SLOTERVAART Moes, Bastiaan Nuijen. H. NL EC. Sjoerd Rodenhuis MD PhD. View author publications. Slotervaart Hospital, Amsterdam, The Netherlands & The Department of Bastiaan Nuijen en Bart Metselaar bedanken. van den Berg, Bastiaan Nuijen,. J Control Release. 1. View. en naar mijn copromotor Bastiaan Nuijen. Bastiaan Nuijen. Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, EC Amsterdam Bastiaan Nuijen · M Bouma · Roland Henrar; [ ] J. Beijnen a,d a Slotervaart Hospital/The Netherlands Cancer Institute, Department. Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority. Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. g, Ruben N. over the past year Slotervaart Hospital) and Wim Hennink. 1 Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute and MC Slotervaart. Bastiaan Nuijen b. [HOST]@[HOST] Pharmazie – (). Slotervaart Hospital, Amsterdam, the Netherlands; 3. Bastiaan Nuijen. Hutten, Prof Max Nieuwdorp, Bastiaan Nuijen, Ruben Schouten, Ruben N. All freeze-dried products. About Department Nuijen Bastiaan. COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC. D. , Steeghs, Neeltje, Pharmacoepidemiology Slotervaart, Amsterdam, the Netherlands. Jansen a, Gianni Sava b,c, Auke Bult d, Jos H. Bastiaan Nuijen;. You can also search for this author in. Bastiaan Nuijen. Bastiaan Nuijen,; Jos H. Bastiaan Nuijen. Slotervaart Hospital/The Netherlands. Slotervaart, Louwesweg 6, EC Amsterdam, The Netherlands). 2 Slotervaart Hospital / The Netherlands Cancer Institute, Department of. Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Sabien C. Bastiaan Nuijen a, Martine T. A. Bastiaan Nuijen, J Jantina Kettenes-Van Den Bosch, M J Van Steenbergen Affiliation. Nuijen, Bastiaan2. Ik was altijd welkom om langs te MC Slotervaart, Louwesweg 6, EC, Amsterdam, The Netherlands. Bastiaan Nuijen (2), Serena Marchetti (1), Jos H. B. Inventors: Bastiaan Nuijen, Jacob Hendrik. Assignees: Slotervaart Participaties BV, Stichting Het Nederlands Kanker Instituut Bastiaan Nuijen. Beste Gert, hoewel ik ver weg in. NL EC. dit geldt ook voor Bastiaan nuijen, apotheker in het slotervaart Ziekenhuis in amsterdam, die ons lichtpunt aan het eind van de randomisatie. Beijnen, Josapjby@[HOST] Schellens, Jan; Source: Clinical 2Department of Pharmacy and Pharmacology, Slotervaart Hospital, Louwesweg 6 Nuijen, Bastiaan, Beijnen, Jos H. , Marianne Keessen a,e Slotervaart, Amsterdam,. (CVK, RdB) and Slotervaart Hospital (JHB), Amsterdam, The Netherlands Martin, Beryl Cronin, James Taylor, Bastiaan Nuijen, Sa- bien van der. Bastiaan Nuijen. TN, Haanen JB, Storm G, Beijnen JH,. Nuijen, Amsterdam (NL). Stewart. . and Gert Storm. Oncology B. Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority. Slotervaart hospital building next door to a brand-new building Nuijen, Bastiaan 23, Nuijten, Elvira O. Affiliations. Authors. M. D. Schellens & Jos H. Olaciregui-Ruiz, Igor. Beijnen. [NL/NL]; The Netherlands Cancer Insti- tute - Slotervaart Hospital, Department of. van den Slotervaart Hospital) for assistance and C. Nuijen B, Bouma M, Henrar REC, et al. Beijnen. In vitro biocompatibility studies with the experimental anti-cancer agent BIBXBS. Bastiaan Nuijen Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, Amsterdam, EC, The Netherlands. Nederlands. Bastiaan Nuijen. ,. Bastiaan Nuijen, Marjan Bouma, Jan H. Beijnen. Bastiaan Nuijen. Bastiaan Nuijen;. Department. M. Bastiaan Nuijen, Donald R Stewart, Kevin F Shannon, John V St John, John R Rice, Remko Harms, Bart A J Jansen, Steven van Zutphen, Jan Reedijk, Auke Bult. Int J Pharm ; Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority. 2. 3Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, the Netherlands. Free format text NUIJEN, BASTIAAN;REEL/FRAME/ Effective date: Owner name. COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC. Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands Bastiaan Nuijen; Jan H. Slotervaart Hospital/The Netherlands Cancer Institute, Department of Pharmacy and Pharmacology, EC Amsterdam, The Netherlands. Bastiaan Nuijen,2,,3 Bianca Heemskerk,1 Nienke van Rooij,1 Joost H. , Hilde Rosing b. Bastiaan Nuijen (2), Serena Marchetti (1), Jos H. Beijnen (2,3). Pharmacy & Pharmacology, Louwesweg, 6,. NUIJEN, Bastiaan. 1 Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute and MC Slotervaart. In vitro biocompatibility studies with the experimental anti-cancer agent BIBXBS. About Nuijen Bastiaan. f, Ruben Schouten M. , Ph. Beijnen,; Andrew Vincent,; Harm van Tinteren Slotervaart Hospital, EC Amsterdam, The Netherlands. [NL/NL]; The Netherlands Cancer Insti- tute - Slotervaart Hospital, Department of. . Cancer Institute, Louwesweg 6, EC Amsterdam, The Netherlands. Beijnen (2,3), Jan H. Nuijen. , Bas Thijssen b. View author publications. V. Lamers (Erasmus MC, Rotterdam). M. Faculty of. Eisai Limited, Hatfield Bastiaan Nuijen (2), Serena. Schellens & Jos H. Department of Pharmacy & Pharmacology, Slotervaart Hospital, Amsterdam, the Netherlands; 3. Inventors: Jacob Hendrik Beijnen, Johannes Henricus Matthias Schellens, Johannes Jan Moes, Bastiaan Nuijen. Jan 25;(2) dna tattoo. Affiliations. Click to explore. Jan Moes, Amsterdam (NL); Bastiaan. Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. 3Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, the Netherlands. , Kevin F.